GKFX backs Rising Sum

globalequities

Online broker GKFX has begun distributing an equities-based trading platform called Rising Sum, in a move to diversify its product range beyond foreign exchange and into equity derivatives.

The platform was launched in January 2013, and uses investment holding company Berkshire Hathaway's acquisition criteria, combining quantitative and qualitative analysis to identify underlying potential in the equities markets. For example, Rising Sum identified both Lubrizol and IBM as value investments before Berkshire Hathaway's chief executive, Warren Buffett, paid $20 billion for them.

The screening tools have been demonstrably successful in identifying undervalued companies with sound fundamentals – the type of companies that are more likely to see market corrections around the time of earnings releases. Rising Sum publishes Value Alerts that highlight when these events take place, giving traders plenty of time to prepare.

Amir Gharred, head of UK sales at GKFX in London, says: "Our mission is to offer a strong selection of advanced and emerging platforms so that our customers can trade a variety of products. Rising Sum is an exciting and creative development for the equities market-place, and it brings a new and powerful dimension to the CFD trading community."

"We have identified many opportunities for investors across the US and UK markets. By concentrating on company fundamentals, we have shown how we can outperform the market in key areas," says Kevin Ashby, chairman of Rising Sum in London.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact customer services - www.fx-markets.com/static/contact-us, or view our subscription options here: https://subscriptions.fx-markets.com/subscribe

You are currently unable to copy this content. Please contact info@fx-markets.com to find out more.

You need to sign in to use this feature. If you don’t have a FX Markets account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: